Shakeel Virk
Kingston, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Strengthening Biomarker Research in Canadian Cancer Clinical Trials: A Pathology-Focused White Paper.
Journal: Current oncology (Toronto, Ont.)
Published: April 29, 2026
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Journal: Breast cancer research and treatment
Published: March 25, 2025
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2024
Plasma versus Tissue Tumor Mutational Burden as Biomarkers of Durvalumab plus Tremelimumab Response in Patients with Metastatic Colorectal Cancer in the CO.26 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 26, 2024
Objective quantification of BCL2 protein by multiplex immunofluorescence in routine biopsy samples of diffuse large B-cell lymphoma demonstrates associations with survival and BCL2 gene alterations.
Journal: Leukemia & lymphoma
Published: January 17, 2020
Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples.
Journal: Journal of visualized experiments : JoVE
Published: January 22, 2019
An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: May 14, 2018
Abundant expression of BMI1 in follicular lymphoma is associated with reduced overall survival.
Journal: Leukemia & lymphoma
Published: December 19, 2017
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 28, 2017
Impact of serum HER2, TIMP-1, and CAIX on outcome for HER2+ metastatic breast cancer patients: CCTG MA.31 (lapatinib vs. trastuzumab).
Journal: Breast cancer research and treatment
Published: February 23, 2017
First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16.
Journal: Gynecologic oncology
Published: December 04, 2015
Last Updated: 09/26/2026